SciELO - Scientific Electronic Library Online

 
vol.59 número1SYNTHESES AND STRUCTURAL STUDIES ON COORDINATION COMPOUNDS OF POLYSTYRENE-ANCHORED SCHIFF BASE WITH SOME METAL IONSSULFONIC ACID FUNCTIONALIZED NANOPOROUS SILICA (SBA-PR-SO3H) AS AN EFFICIENT CATALYST FOR THE ONE-POT SYNTHESIS OF 2H-INDAZOLO[1,2-B]PHTHALAZINE-TRIONES índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Journal of the Chilean Chemical Society

versión On-line ISSN 0717-9707

J. Chil. Chem. Soc. vol.59 no.1 Concepción mar. 2014

http://dx.doi.org/10.4067/S0717-97072014000100005 

 

SPECTROPHOTOMETRIC DETERMINATION OF AMITRIPTYLINE HCl IN PURE AND PHARMACEUTICAL FORMS

 

K. SUSMITHA1, M. THIRUMALACHARY1 , T. CHARAN SINGH2 AND G. VENKATESHWARLU*

1 Department of Chemistry, Jawaharlal Nehru Technology University Kukatpally, Hyderabad-500 085,
2
Department of Chemistry, G. Narayanamma Institute of Science & Technology
* Department of Chemistry, Nizam College, Hyderabad 500001, A.P. India
e-mail: venkateshwarlugoud@yahoo.com


ABSTRACT

Five spectrophotometric methods for determination of Amitriptyline HCl have been developed, validated and applied for the assay of the drug in pharmaceuticals. Methods A, B and C are based on ion pair complexation of drug, in acidic buffers, with triphenylmethane dyes viz., Bromothymol blue (BTB), Bromophenol blue (BPB) and Bromocresol purple (BCP). The complexes are extracted into chloroform and absorbance is measured around at 415 nm as function of concentration of the drug. The stoichiometry of the complex is found 1:1 in each case. Method D depends upon charge transfer complexation of neutralized drug with iodine which produces iodide ion whose absorbance at 366 nm is measured as function of concentration of the drug. This complex, too, has 1:1 composition as determined by Job's method. Method E is developed on the basis of oxidation of the drug with alkaline KMnO4 which generates green colored manganate ion with λmax 610 nm. As the intensity of green color increased with increasing time kinetics of the reaction is followed and calibration curves are constructed by using initial rate and fixed time methods. Excellent recovery studies with high accuracy and precision indicate that the methods can be successfully used in industries for the assay of drug in pure form and pharmaceuticals.

Keywords: Spectrophotometry, Amitriptyline HCl , Bromothymol blue, Bromophenol blue, Bromocresol purple, Iodine, Alkaline KMnO4


 

1. INTRODUCTION

Amitriptyline HCl (AMT) chemically [3-(10, 11-dihydro-5H-dibenzol [a, d] cyclohept-5-ylidene) propyldimethylamine] hydrochloride constitute an important class of neurotherapeutics 1 belonging to first generation of antidepressant drug 2, 3 It may be used to treat depression, irritable bowel syndrome, diabetic neuropathy, post-traumatic stress disorder and for migraine prophylaxis. Various analytical methods developed for determination of amitriptyline HCl viz., spectrophotometric 4 - 11, spectrofluorometric 12 , flow injection method 13, atomic absorption spectroscopic 14,conductometric15,16, voltammetric 17, UPLC-MS/MS 18 MEPS by LC&GC-MS19, Electrogenerated Chemiluminescence 20 and HPLC 21 methods have been enumerated.

Table I. Comparison with other quantification methods for the determination of Amitriptyline hydrochloride

 
 
From the comparison table it is clear that the methods used so far for quantification of AMT suffer from involving costly equipment7,12,19,20 or costly chemicals 4,6 or instruments with low sensitivity8 and not useful for routine laboratory analysis. Therefore it seems necessary to develop a sensitive, simple and rapid determination of Amitriptyline HCl. In the present communication we report five quantification methods viz., A, B, C, D, and E which have been developed and validated for quantification of Amitriptyline HCl both in pure and pharmaceutical forms.

2. EXPERIMENTAL

2.1 Instruments

The UV--Visible spectra of the samples were recorded on SHIMADZU 140 double beam, Thermo Nicolet 1000 and ELICO 159 UV-Visible single beam spectrophotometers using quartz cells of 10 mm path length. An Elico model Li-120 pH meter was used for pH measurement.

2.2 Materials

HPLC grade chloroform, 1, 2 Dichloroethane (DCE), Analytical grade (AR) HCl, Sodium acetate, KMnO4, Sodium hydroxide and dyes viz., a) BTB b) BPB c) BCP supplied by Sd Fine Chemicals, Mumbai were used in the study. Iodine (BDH, Poole, UK) was twice sublimed and preserved in vacuum desiccator (mp 113.6 -3oC). Iodine in 1, 2 dichloroethane was freshly prepared (daily) by dissolving 254mg solute in 50mL of solvent (4.0x10-3 M). The drug was procured from Aurobindo Pharmaceiticals, Hyderabad, as gift sample.

Neutralisation is carried out by dissolving 100 mg of AMT in 10mL of distilled water and solution is transferred into 100 mL separating funnel and rendered alkaline with 5mL of 0.45M NaOH solution. The liberated base is extracted with three times , each with 25mL of 1,2 Dichloroethane. The solution is further diluted with same solvent to obtain the working solution.

2.3. Methods A, B and C

The methods A, B and C are based on the interaction of the drug with Bromothymol blue (BTB), Bromophenol blue (BPB) and Bromocresol purple (BCP) respectively, to form chloroform extractable ion pair complexes (Scheme 1) which absorb around 415 nm. (Fig. 1) The absorbance of this band increases with increasing the concentration of the drug and formed a basis for the quantification of the drug. The dyestuffs were used as 0.025% solutions in doubly distilled water. Sodium acetate-hydrochloric acid buffers of pH 2.8, 2.5 and 2.5 were prepared by mixing 50ml of 1.0 M sodium acetate solution with 49.50 mL, 50.50mL and 50.50 mL of 1.0 M HCl solution respectively and diluted to 250 mL with doubly distilled water. The pH of each solution was adjusted to an appropriate value with the aid of a pH meter.

 

Bromothymol blue: R1 = isopropyl, R2 = CH3
Bromophenol blue: R1 = Br, R2 = H
Bromocresolpurple: R1 = .CH3, R2 = H

 

Scheme 1 Amitriptyline HCl - dye complex

 

Figure 1. Absorption spectra of Amitriptyline Hydrochloride - dyes complex extracted into 10 mL chloroform:

(a) drug = 20 μg mL-1 + 5 mL of 0.025% BTB + 5 mL of pH 2.8 buffer;
(b) drug = 20 μg mL-1 + 5 mL of 0.025% BPB + 5 mL of pH 2.5 buffer;
(c) drug = 22.5 μg mL-1 + 5 mL of 0.025% BCP + 5 mL of pH 2.5 buffer,
(d) drug = 0 μg mL-1 + 5 mL of 0.025% Dye + 5 mL of buffer

2.4. Method D

The method depends upon the interaction of neutralized drug with Iodine that generates iodide ion having an absorption band at 366 nm. (Fig. 2) The absorbance of this band increases with increasing the concentration of the drug and formed a basis for the quantification of the drug. Mixing the solution of iodine prepared in DCE with AMT resulted in a change of violet color of iodine into light brown to pale yellow and as a consequence, absorption spectra exhibited a new band of 366nm. This is attributed due to I3 - ion formed by the interaction of iodine with drug. (Scheme 2).

 

Figure 2. Absorption spectra (2) reaction product of 5 μg mL-1 Amitriptyline hydrochloride with iodine in 1, 2 Dichloroethane (3) iodine

 

Scheme — 2

2.5. Method E Kinetic method

The method depends on the oxidation of the drug with alkaline KMnO4 (1x10-2 M) to produce Manganate ion which absorbs at 610 nm (Fig. 3) and formed a basis for quantification of drug. A solution of 0.45 M NaOH is used to produce required alkalinity. Mixing the solutions of permanganate and the drug slowly developed green color and hence kinetics of the reaction was followed spectrophotometrically. The initial rate and fixed time methods are followed for the determination of AMT. The literature survey reveals that Amitriptyline undergoes oxidation at exocyclic double bond and gives rise to dibenzosuberone 22. (Scheme -3)

 

Figure 3. Absorption spectra of (a) Drug (b) KMnO4 (1 x10-2 M) (c) Reaction product of 10μg mL-1 Amitriptyline hydrochloride with alkaline KMnO4

 

Scheme — 3 Oxidation of Amitriptyline HCl with alkaline KMnO4

2.6. Calibration curves for method A, B and C

Different aliquots of drug solution were transferred into 125 mL separating funnel. To this 5 mL of buffer, 5 mL of dye were added and total volume was made up to 20 mL with water. 10 mL of chloroform was added and the contents were shaken for 5 min. The two layers were allowed to separate for 5 min and the organic layer was separated and absorbance of yellow colored solution which is stable at least for 3 hr is measured at 415 nm against blank similarly prepared. The same procedure of analysis is followed either for assay of pure drug or for dosage form. The calibration graphs are linear over a range of drug 1.25 - 25μgmL-1 (BTB), 1.5 - 25μgmL-1 (BPB), 2.0 - 25μgmL-1 (BCP).

2.7. Calibration curve for method D

Into separate 10mL of volumetric flasks different aliquots of AMT solution was transferred followed by the addition of 1mL of iodine solution. The volume was completed using the 1, 2 dichloroethane solvent and the absorbance was measured against reagent blank at 366nm and calibration curve is linear over a range of drug 2.5 - 25μgmL-1

2.8. Calibration curve for method E

The calibration curves are constructed by using initial rate method and fixed time method.

2.8.1. Initial rate method

Aliquots of 1 to 8 mL of Amitriptyline HCl solution containing 2.5 mg mL-1 of drug were pipetted into a series of 10 mL standard flasks. To each flask, 1.0 mL of 0.45 M NaOH and 1 mL of 1x 10-2 M potassium permanganate were added successively and then diluted with distilled water at 25 ± 10C. The contents of each flask were mixed well, and the increase in absorbance as a function of time was measured at 610 nm. The initial rate of the reaction at different concentrations was evaluated by deferring the slope of the tangent to the absorbance-time plot. The calibration graphs in the range 6.25 -50μgmL-1 were obtained by plotting the initial rate of reaction versus the molar concentration of the Amitriptyline HCl (Fig . 4)

 

Figure 4. Calibration curves

2.8.2. Fixed time method

A fixed time of 25 min was selected for the fixed time method. At this time the absorbance of reaction mixture was measured at 610 nm against a reagent blank prepared similarly. The calibration curve was obtained by plotting the absorbance against concentration of Amitriptyline HCl.

2.9. Assay of drug in pharmaceuticals

2.9.1. Procedure for the assay of pure drug

Five different solutions of pure drug in the range of calibration curve were selected and the recovery experiments were performed. The recoveries and their relative standard deviation are tabulated in Table III.

Table II. Performance data for the proposed methods.

 
 

Y= a*C + b, Where C is the concentration in μgmL-1

Table III. Application of proposed methods for the determination of AMT in pure form.
 
 
Each result is the average of five separate determinations. *Values in parenthesis are the tabulated t and F values at p=0.0523

2.9.2. Procedure for the assay of dosage forms

Five tablets of Elavil 10 mg with composition Amitriptyline HCl -10 mg, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, hydroxyl propyl methyl cellulose, polyethylene glycol, carnauba wax are powdered and dissolved in doubly distilled water and stirred thoroughly, filtered through a Whatman No. 42 filter paper. This solution was transferred into 100 mL standard volumetric flask and diluted with doubly distilled water as required. Different solutions of drug in the range of calibration curve were chosen and its quantify was estimated using the calibration curve and the results of the recovery studies are tabulated in Table IV.

Table IV. Application of proposed methods for the determination of AMT in Pharmaceutical form.

 
 

*Values in parenthesis are the tabulated t and F values at p=0.0523

3. RESULTS AND DISCUSSION

3.1. Methods A, B and C

AMT forms ion-pair complexes in acidic buffer with dyestuffs viz., BTB, BPB and BCP which are quantitatively extracted into chloroform. Ion-pair complexes of drug with dyes absorbed maximally at 415 nm (Fig. 1). AMT contains a tertiary nitrogen atom and in strongly acidic medium it exists as a cation and sulphonic acid group present in the dyes that is the only group undergoing dissociation in the pH range 1-5. Finally the protonated AMT forms ion-pairs with the dyestuff which is quantitatively extracted into chloroform.

3.2. Stoichiometry

In order to establish molar ratio between AMT and dyestuffs used, the Job's method of continuous variation has been applied 24. In this method, solutions of drug and dyestuff with identical molar concentrations [8 x 10-5M] were mixed in varying volume ratios in such a way that the total volume of each mixture is the same. The absorbance of each solution was measured and plotted against the mole fraction of the drug, [drug]/[drug]+[dyestuff] . This measurement showed that 1:1 complex was formed.

The Job's method of stoichiometry is also applied for Iodine with AMT which indicated the charge transfer complex formed is of 1:1 composition (Fig 5).

 

Figure 5. Jobs continuous variation plot-

The stoichiometric ratio between Amitriptyline and potassium permanganate was evaluated by limiting logarithmic method 25. The method involves two sets of experiments. In the first set the concentration of AMT was varied keeping a constant concentration of KMnO4, while in the second set, the concentration of AMT was kept constant and the KMnO4 concentration was varied. Log absorbance versus log [AMT] or [KMnO4] was plotted to evaluate the slopes of the respective lines. The slope was found to be unity in each case thus indicating the molar combining ratio of 1:1 between Amitriptyline and potassium permanganate.

3.3. Formation constants

The formation constants for methods A, B and C was estimated from Job's plot by following method described by Likussa and Boltz 26, and Momoki et al 27.The method involves drawing the tangents at the origin of Job's plot from both side and the absorbance at intersection point is taken for 100% complexation. The absorbance at peak height of Job's plot is taken for (100 - x) % where x is the % degree of dissociation of the complex. The instability constant, K' = Cx/ (100 - x) is calculated, where C is concentration of drug used for Job's method. The reciprocal of K' is the required stability constant K.

3.4. Formation constant for method E

Formation constant (K) has been evaluated by using Benesi-Hildebrand equation 28

Where d is absorbance, ε is molar absorptivity, A0 and D0 are initial concentrations of acceptor [I2] and donor [drug] respectively. A plot of [A0]/d Vs 1/ [D0] yields a straight line whose slope and intercept gives the value of K.

3.5. Optimization of the factors affecting the absorbance.

The factors effecting the absorbance of ion pair complexes like pH and volume of the dye, in methods A, B and C have been optimized. 1.8 mL of BTB and buffer of pH 2.8, 1.6 mL of BPB and buffer of pH 2.5 and 1.7 mL of BCP and buffer of pH 2.5 are found to be optimal for methods A, B and C respectively. However 5 mL of each dye is used, at optimal pH, in the study to ensure complete extraction of the drug. Similarly the 1 mL of iodine for method D and 1 mL of KMnO4, 1 mL of 0.45 NaOH for method E are found to 4 be optimal and hence are used in the study.

3.6. Validation of the proposed methods

The proposed method have been validated in terms of guidelines proposed by ICH 29 viz., selectivity, specificity, accuracy, precision, limits of calibration curve, LOD, LOQ, robustness, ruggedness and regression equation. The student t-test and variance F-test have been performed in comparison with a reference method. To test the reproducibility of the proposed methods, five replicate determinations of 15.0ug mL of AMT were made. The coefficient of variation was found to be less than 1.2% for all the procedures.

The proposed methods have been successfully applied to the determination of AMT in pharmaceutical preparations. The results obtained and shown in Table II were compared to those obtained by a reference method 4 by means of t-test at 95% confidence level. In all cases, the average results obtained by proposed methods and reference method were statistically identical, as the difference between the average values had no significance at 95% confidence level.

The proposed methods are simple, sensitive and reproducible and can be used for routine analysis of AMT in pure form and in formulation

4. CONCLUSIONS

The proposed spectrophotometric methods present selective and simple, specific and inexpensive analytical procedures for determination of AMT, in pure or in tablet dosage forms without interference from common excipients. Moreover, the developed methods are time saving and do not require elaborate treatments associated with chromatographic methods. These attributes, make them suitable for routine analysis in quality control laboratories.

ACKNOWLEDGEMENTS

Authors are thankful to the Head, Department of Chemistry and Principal Nizam College, Head Department of Chemistry, Jawaharlal Nehru Technological University Hyderabad, for providing laboratory facilities for this work.

 

REFERENCES

1. Goodman and Gilmans,The Pharmaceutical Basis of Therapeutics, 12th edition , 2010.         [ Links ]

2. Kirk- othmer, Encyclopedia of Chemical Technology, John Wiley & sons, 27th volume, 2004.         [ Links ]

3. W.C. Bowman and M.L. Rand, Textbook of Pharmacology, Blackwell Science publication, 1992.         [ Links ]

4. Pankaj Soni, Santosh K. Sar, Rajmani Patel, JASMI, 2, 103, (2012)        [ Links ]

5. A.A Omran, A.Y. El-Sayed, A.M. Shehata, M. Ahmed, M.A. El-Erian, J. Applied. Sci. Res. 3, 1730, (2007).         [ Links ]

6. M.G. Gehad, A.F. Nour El-Dien, Faten, M.A. Nehad, Spectrochimica Acta. 68, 1244, (2007).         [ Links ]

7. Seja Patel, N.J. Patel, Indian J.PharmSci. 71, 472, (2009)        [ Links ]

8. M.G. Gehad, A.F. Nour El-Dien, S.M. Khalil, M.A.Nehad, Spectrochimica Acta. 65, 1221, (2006).         [ Links ]

9. J. O. Onah, Global. J. Pure. App. Sci. 11, 237, (2005).         [ Links ]

10. J. Karpinska, J. Szostak, Spectrochimica Acta. 61, 975, (2005)        [ Links ]

11. A. Tehssen, A. A Kazi, I. H. Mohamed, A. Tal, Anal. Letters. 33, 2477, (2000).         [ Links ]

12. F. A. Mohamed, H. A. Mohamed, S. A. Hussein, S. A. Ahmed, J. Pharm. Biomed. Anal. 39, 139, (2005),         [ Links ]

13. R.M. El-Nashar, N.T. Ghani Abdel, A.A. Bioumy, Microchemical J. 78, 107, (2004).         [ Links ]

14. E.M. Elnemma, F.M. ElZawwy, S. M. Hassan, Saad, Microchimica Acta. 110, 79, (1993).         [ Links ]

15. T. Ghani Nour, A. El. Nashar, R. M. Bioumy, A. Abeer, FABAD. J. Pharm. Sci. , 29, 195, (2004).         [ Links ]

16. C. Jessica, R. Alberto, A. Emillio , J. Elena, J. Incl. phenom Macrocycl che. (2007).         [ Links ]

17 W. Lu, S. A. Shamsi, T.D. McCarley, I.M. Warner, Electrophoresis, 19, 2193, (1998).         [ Links ]

18. K.L. Johnson-Davis, J.M. Juenke, R. Davis, G.A. McMillin, Methods. Mol. Biol. 902, 175, (2012)        [ Links ]

19. Susheela Rani, Ashwini Kumar, Ashok Kumar Malik, Baldev Singh, MS, Chromatographia. 74, 235, (2011)        [ Links ]

20. G.M. Greenway, Sarah J.L. Dolman, Analyst, 124, 759, (1999)        [ Links ]

21. J. Trocewicz, J. Chromatogr. B, 801, 213, (2004)        [ Links ]

22. S.D Lamani, S.T. Nandibewoor , J. Thermodyn Catal. 2,110, (2011)         [ Links ]

23. J.C. Miller, J.N. Miller, Statistics and chemometrics for Analytical Chemistry, Harlow, England, 2005.         [ Links ]

24. P. Job, Anal. Chim Acta. 9, 113, (1928).         [ Links ]

25. J. Rose Advanced Physicochemical Experiments, Pitman, London, UK, 1964.         [ Links ]

26. W. Likussar D.F. Boltz, Anal. Chem. 43, 1265, (1971).         [ Links ]

27. K. Momoki, J. Sekino, H. Sato, N. Yamaguchi, Anal. Chem. 41, 1286, (1969).         [ Links ]

28. H. A. Benesi, J. R Hildebrand, J. Am. Chem. Soc. 71, 2703, (1949).         [ Links ]

29. International Conference on Harmonization (ICH) of Technical Requirement for the Registration of Pharmaceuticals for Human use, Validation of analytical procedures: definitions and Terminology Genera (1996).         [ Links ]

 


(Received: December 18, 2012 - Accepted: January 15, 2013)